(NTLA) Intellia Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Intellia Therapeutics | (NTLA) share price targets
Complete technical analysis of Intellia Therapeutics (NTLA) by charts plus indicators, forecast predictions and share price targets for Intellia Therapeutics (NTLA)
Intellia Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-12-12 View latest technical analysis
10 day averaged volume of Intellia Therapeutics is 2762792
| Date | Daily Closing Price | Open | High | Low | Volume |
| 12 Thu Dec 2024 | 13.55 | 14.05 | 14.05 | 13.46 | 0.453 times |
| 11 Wed Dec 2024 | 14.10 | 14.75 | 14.82 | 13.88 | 0.597 times |
| 10 Tue Dec 2024 | 14.72 | 14.58 | 14.90 | 14.27 | 0.567 times |
| 09 Mon Dec 2024 | 14.62 | 14.90 | 15.29 | 14.60 | 0.686 times |
| 26 Tue Nov 2024 | 14.73 | 14.65 | 14.77 | 14.17 | 0.788 times |
| 26 Tue Nov 2024 | 14.73 | 14.65 | 14.77 | 14.17 | 0.788 times |
| 25 Mon Nov 2024 | 14.79 | 14.89 | 15.24 | 14.41 | 1.389 times |
| 22 Fri Nov 2024 | 14.30 | 14.00 | 14.58 | 13.64 | 0.872 times |
| 21 Thu Nov 2024 | 13.80 | 13.23 | 14.39 | 13.23 | 1.437 times |
| 20 Wed Nov 2024 | 13.12 | 14.15 | 14.27 | 12.82 | 1.621 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 13.8, but if it comes above 13.8, then a intra day buy could be more profitable.
If you take a sell trade below 13.8, then use 13.8 as stoploss and 12.4 as target. However if you take a buy trade in stock , then use 13.8 as stoploss and 14.95 as target.
Share price targets for Intellia Therapeutics (NTLA)
| Target Type | Value |
| Downside Target | 12.82 |
| Downside Target | 13.46 |
| Upside Target | 13.95 |
| Upside Target | 14.77 |
| Upside Target | 15.20 |
| Upside Target | 17.83 |
| Upside Target | 19.21 |
| Upside Target | 20.82 |
| Upside Target | 21.47 |
| Upside Target | 23.76 |
| Upside Target | 26.63 |
Intraday share price targets for Intellia Therapeutics (NTLA)
| Target Type | Value |
| Downside Intraday Target | 12.91 |
| Downside Intraday Target | 12.27 |
| Upside Intraday Target | 14.74 |
| Upside Intraday Target | 15.93 |
| Upside Intraday Target | 14.1 |
Weekly technical analysis of Intellia Therapeutics (NTLA)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 12 Thu Dec 2024 | 13.55 | 14.90 | 15.29 | 13.46 | 2.921 times |
| 26 Tue Nov 2024 | 14.73 | 14.65 | 14.77 | 14.17 | 0.362 times |
| 26 Tue Nov 2024 | 14.73 | 14.89 | 15.24 | 14.17 | 0.302 times |
| 22 Fri Nov 2024 | 14.30 | 14.49 | 15.20 | 12.82 | 1.519 times |
| 15 Fri Nov 2024 | 13.97 | 17.24 | 17.83 | 13.96 | 0.996 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Intellia Therapeutics (NTLA)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 12 Thu Dec 2024 | 13.55 | 14.90 | 15.29 | 13.46 | 0.113 times |
| 26 Tue Nov 2024 | 14.73 | 14.21 | 17.83 | 12.82 | 0.92 times |
| 31 Thu Oct 2024 | 14.22 | 20.56 | 21.47 | 13.95 | 2.077 times |
| 30 Mon Sep 2024 | 20.55 | 22.35 | 23.76 | 19.21 | 1.079 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Intellia Therapeutics (NTLA)
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Intellia Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Intellia Therapeutics in short term but the buy signal is initial and weak.
Intellia Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Intellia Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Intellia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 14.16 and Intellia Therapeutics (NTLA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Intellia Therapeutics (NTLA) stock. Volume based technical analysis of Intellia Therapeutics (NTLA) stock is negative.
Intellia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Intellia Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Intellia Therapeutics in short term but the buy signal is initial and weak.
Intellia Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Intellia Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Intellia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 14.16 and Intellia Therapeutics (NTLA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Intellia Therapeutics (NTLA) stock. Volume based technical analysis of Intellia Therapeutics (NTLA) stock is negative.
Intellia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.